Nature Biotechnology | Aureka Wins the Global Blinded AI Antibody Benchmark: AI Design Surpasses the Best Experimental ResultUnusual Whales·1 day ago, 07:45 PM
U.S. Stock Market Midday Update: AARD up 12.22%! IPO misleading allegations lead to class action lawsuit, legal risks intensify market volatilityPrice Alert·Aug 21 at 11:48 AMAARD-2.79%
Yubo International Biotech Ltd 2Q 2026: Revenue $165.49K, Net income ($268.72K), EPS $0— 10-Q SummaryTradingView·Aug 14 at 05:41 AMYBGJ0.00%
Yubo International Biotech Q2 FY26 net loss widens 7.6% to $268,721; revenue holds at no revenuePUBT·Aug 14 at 05:38 AMYBGJ0.00%
Yubo International Biotech Limited | 10-K: FY2025 Revenue: USD 12.35 KEarnings Watch·Mar 31 at 03:14 PMYBGJ0.00%
Chungui International BioTech, Biofermented Health Wines, Files for Nasdaq Capital Market IPOTradingView·Mar 12 at 04:37 PMYBGJ0.00%JYB
Bure Equity Hit by Sharp NAV Decline as Tech Portfolio Repriced in 2025Tip Ranks·Feb 19 at 03:03 AMIHI-1.39%XLV-1.13%
King International Investment Adds Governance Details on New Co-Chairman WangTip Ranks·Jan 12 at 05:11 PMYBGJ0.00%
Yubo International Biotech Limited | 10-Q: FY2025 Q3 Revenue: USD 0Earnings Watch·Nov 14, 2025 at 05:14 AMYBGJ0.00%
Yubo International Biotech Limited | 10-Q: FY2025 Q2 Revenue: USD 0Earnings Watch·Aug 13, 2025 at 03:19 PMYBGJ0.00%
Yubo International Biotech Limited | 10-Q: FY2025 Q1 EPS: USD 0Earnings Watch·May 14, 2025 at 05:04 AMYBGJ0.00%
